← All diseases
Cancer
Ovarian cancer
Do you want to receive a message when there is new research about Ovarian cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence explaining what was investigated — and you will receive a message as soon as there is new research about Ovarian cancer. View what Premium costs.
Publications and studies (2868)
- Cathepsins and cancer risk: a Mendelian randomization study. (2024/05/31) ♡
- Global research trends in liquid biopsy for ovarian cancer from 1999 to 2023: A 25-year bibliometric analysis. (2024/05/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential. (2024/05/20) ♡
- The association between being breastfed in infancy and risks of cancer in adulthood-a UK Biobank study. (2024/05/14) ♡
- Associations between Two Dietary Quality Scores and Pancreatic Cancer Risk in a US National Prospective Cohort Study. (2024/05/01) ♡
- Assessing ovarian stimulation with letrozole and levonorgestrel intrauterine system after combined fertility-sparing approach for atypical endometrial lesions: a retrospective case-control study. (2024/05/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Fertility preservation in patients undergoing gonadotoxic treatments: a Canadian Fertility and Andrology Society clinical practice guideline. (2024/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. INSR-Related Severe Insulin Resistance Syndrome. (2024/04/25) ♡
- The causal association between artificial sweeteners and the risk of cancer: a Mendelian randomization study. (2024/04/22) ♡
- Breast cancer risk associated with BRCA1 and BRCA2 pathogenic variants in the Eastern Chinese population. (2024/04/17) ♡
- Transcriptomic profile of premature ovarian insufficiency with RNA-sequencing. (2024/04/09) ♡
- Danggui Shaoyao San protects cyclophosphamide-induced premature ovarian failure by inhibiting apoptosis and oxidative stress through the regulation of the SIRT1/p53 signaling pathway. (2024/04/06) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Exploring the logic and conducting a comprehensive evaluation of AdipoRon-based adiponectin replacement therapy against hormone-related cancers-a systematic review. (2024/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Adult extrarenal teratoid Wilms' tumor: A case report and review of literature. (2024/04/01) ♡
- Poorly controlled type 1 diabetes mellitus seriously impairs female reproduction via immune and metabolic disorders. (2024/04/01) ♡
- Histomorphologic analysis of ovarian tumors according to the New 2020 WHO classification of female genital tumors. (2024/04/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Imatinib in c-KIT-mutated metastatic solid tumors: A multicenter trial of Korean Cancer Study Group (UN18-05 Trial). (2024/04/01) ♡
- Genitourinary Syndrome of Menopause: Pathophysiology, Clinical Presentation, and Differential Diagnosis. (2024/03/01) ♡
- Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Asbestos Exposure and Ovarian Cancer: A Meta-analysis. (2024/03/01) ♡
- The Network Pharmacology Analysis of Tonifying Yang Formula for the Treatment of Diminished Ovarian Reserve. (2024/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of unilateral sclerosing stromal tumor of the ovary in a postmenopausal female. (2024/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report. (2024/02/02) ♡
- Modeling of senescence-related chemoresistance in ovarian cancer using data analysis and patient-derived organoids. (2024/02/02) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful Treatment of a Case of Crescentic Glomerulonephritis in a Patient with Primary Peritoneal Carcinoma: A case report. (2024/02/01) ♡
- Ultra-Processed Food Consumption and Mortality: Three Cohort Studies in the United States and United Kingdom. (2024/02/01) ♡
- What is the most pertinent definition of malnutrition in epithelial ovarian cancer to assess morbidity and mortality? (2024/02/01) ♡
- Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy. (2024/02/01) ♡
- Multi-target meridians classification based on the topological structure of anti-cancer phytochemicals using deep learning. (2024/01/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Guizhi Fuling Formulation: A review on chemical constituents, quality control, pharmacokinetic studies, pharmacological properties, adverse reactions and clinical applications. (2024/01/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Research progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells. (2024/01/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Safety of bevacizumab and olaparib as frontline maintenance therapy in advanced ovarian cancer: expert review for clinical practice. (2024/01/29) ♡
- Pb-214/Bi-214-TCMC-Trastuzumab inhibited growth of ovarian cancer in preclinical mouse models. (2024/01/25) ♡
- Exploring the tumor micro-environment in primary and metastatic tumors of different ovarian cancer histotypes. (2024/01/24) ♡
- Corrigendum: Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors. (2024/01/22) ♡
- Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages. (2024/01/22) ♡
- Semisynthesis, Characterization, and Biological Evaluation of Fluorinated Analogues of the Spirobisnaphthalene, Diepoxin-η. (2024/01/12) ♡
- HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial. (2024/01/11) ♡
- A MALDI-TOF mass spectrometry-based method for detection of copy number variations in BRCA1 and BRCA2 genes. (2024/01/11) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: From epilepsy and uterus didelphys to Turner syndrome-associated dysgerminoma. (2024/01/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metastasis and cancer associated fibroblasts: taking it up a NOTCH. (2024/01/10) ♡
- Network pharmacology and experimental validation on yangjing zhongyu decoction against diminished ovarian reserve. (2024/01/10) ♡
- Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk. (2024/01/09) ♡
- Limitations and potential of immunotherapy in ovarian cancer. (2024/01/09) ♡
- Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3. (2024/01/08) ♡
- Specific changes in amino acid profiles in monocytes of patients with breast, lung, colorectal and ovarian cancers. (2024/01/08) ♡
- Ultrahigh resolution lipid mass spectrometry imaging of high-grade serous ovarian cancer mouse models. (2024/01/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Feasibility and safety of combined laparoscopic and transvaginal oocyte retrieval in a woman with vaginal recurrence of cervical adenocarcinoma: a case report. (2024/01/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of gonadotropin-releasing hormone 2 and its receptor in human reproductive cancers. (2024/01/08) ♡
- A real-world study of PARP inhibitors in 75 patients with platinum-sensitive recurrent ovarian cancer from China. (2024/01/08) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.